Amino Acid Disorders 2
The Amino Acid Disorders 2 session will be discussing PKU, Tyrosinemia, Homocystinuria (including cobalamin G&E metab).
Commercial Supporter
This educational activity is supported by an educational grant from Ultragenyx.
Course Materials
Thank you for attending the Amino Acid Disorders 2 session on August 5, 2022! Below are links to access this session's slide deck and recorded course materials.
- View this session's recording here.
Amino Acid Disorders 2_McCandless.pdf
Guest Faculty
Shawn McCandless, MD
University of Colorado
Disclosures
Shawn McCandless, MD, speaker for this activity, is a consultant for Levo Therapeutics, a speaker for Horizon Therapeutics and a researcher for Aardvark Therapeutics, Ultragenyx and Harmony Therapeutics.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Medical
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Other (Internet Live) activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance